NDC 0009-0850 Solu-medrol
Methylprednisolone Sodium Succinate Injection, Powder, For Solution Intramuscular; - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0009 - Pharmacia & Upjohn Company Llc
- 0009-0850 - Solu-medrol
Product Packages
NDC Code 0009-0850-01
Package Description: 1 VIAL in 1 CARTON / 30.6 mL in 1 VIAL
Product Details
What is NDC 0009-0850?
What are the uses for Solu-medrol?
What are Solu-medrol Active Ingredients?
- METHYLPREDNISOLONE SODIUM SUCCINATE 2 g/30.6mL - A water-soluble ester of METHYLPREDNISOLONE used for cardiac, allergic, and hypoxic emergencies.
Which are Solu-medrol UNII Codes?
The UNII codes for the active ingredients in this product are:
- METHYLPREDNISOLONE SODIUM SUCCINATE (UNII: LEC9GKY20K)
- METHYLPREDNISOLONE (UNII: X4W7ZR7023) (Active Moiety)
Which are Solu-medrol Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU)
- SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74)
- WATER (UNII: 059QF0KO0R)
- BENZYL ALCOHOL (UNII: LKG8494WBH)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
What is the NDC to RxNorm Crosswalk for Solu-medrol?
- RxCUI: 1357886 - methylPREDNISolone sodium succinate 2 GM Injection
- RxCUI: 1357886 - methylprednisolone 2000 MG Injection
- RxCUI: 1357886 - methylprednisolone (as methylprednisolone sodium succinate) 2 GM Injection
- RxCUI: 1357888 - SOLU-Medrol 2 GM Injection
- RxCUI: 1357888 - methylprednisolone 2000 MG Injection [Solu-Medrol]
Which are the Pharmacologic Classes for Solu-medrol?
* Please review the disclaimer below.
Patient Education
Methylprednisolone Injection
Methylprednisolone injection is used to treat severe allergic reactions. Methylprednisolone injection is used in the management of multiple sclerosis (a disease in which the nerves do not function properly), lupus (a disease in which the body attacks many of its own organs), gastrointestinal disease, and certain types of arthritis. Methylprednisolone injection is also used to treat certain conditions that affect the blood, skin, eyes, nervous system, thyroid, kidneys, and lungs. It is sometimes used in combination with other medications to treat symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). Methylprednisolone injection is in a class of medications called corticosteroids. It works to treat people with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It also works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.
[Learn More]
Steroids
You may have heard of anabolic steroids, which can have harmful effects. But there's another type of steroid - sometimes called a corticosteroid - that treats a variety of problems. These steroids are similar to hormones that your adrenal glands make to fight stress associated with illnesses and injuries. They reduce inflammation and affect the immune system.
You may need to take corticosteroids to treat:
- Arthritis
- Asthma
- Autoimmune diseases such as lupus and multiple sclerosis
- Skin conditions such as eczema and rashes
- Some kinds of cancer
Steroids are strong medicines, and they can have side effects, including weakened bones and cataracts. Because of this, you usually take them for as short a time as possible.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".